The hepatitis B virus (HBV) vaccine may provide protection through the clon
al expansion of specific memory cells without necessarily having to produce
high serum antibody levels. We develop a mathematical model which distingu
ishes between the accumulation of sensitive memory B and T-helper cells pri
or to a booster and the high circulating antibody levels present in an indi
vidual after a booster. We suggest this immune memory accumulates primarily
in an antigen-independent fashion. These phenomena suggest individuals may
be immune to infection six months after the priming vaccine dose(s) regard
less of whether they receive a booster or not. This hypothesis is supported
by immunogenicity data and by two independent vaccine efficacy trials comp
aring 0, 1 month schedules with 0, 1 and 6 month schedules. (C) 1999 Elsevi
er Science Ltd. All rights reserved.